腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压并发食管胃底静脉曲张患者疗效研究*

doi:10.3969/j.issn.1672-5069.2023.02.027

摘要/Abstract

摘要： 目的比较采用腹腔镜脾切除联合贲门周围血管离断术与开腹手术治疗肝硬化门静脉高压症并发食管胃底静脉曲张(EV)患者的疗效及对门脉血流动力学的影响。方法 2016年3月～2021年3月我科诊治的45例肝硬化门静脉高压症患者,其中20例接受开腹脾切除联合贲门周围血管离断术,另25例接受腹腔镜脾切除联合贲门周围血管离断术治疗。采用放射免疫分析法检测血浆内皮素(ET)、血管紧张素Ⅱ(ATⅡ)和肾素活度(PRA),使用多普勒超声诊断仪测量门静脉血流量PVF)、门静脉血流流速(PVV)、门静脉直径(PVD)和肝动脉血流量(HAF)。结果腹腔镜组手术时间、术中出血量、术中输血量、术后引流管拔除时间、术后排气时间和拆线时间分别为(213.5±20.7)min、(362.8±56.9)ml、(312.5±20.7)ml、(3.8±0.6)d、(2.7±0.4)d和(7.9±1.5)d,与开腹组【分别为(188.4±16.9)min、(415.2±50.7)ml、(349.4±23.6)ml、(5.1±0.9)d、(3.2±0.5)d和(11.3±2.1)d】比,差异显著(P<0.05);术后1 m,腹腔镜组PVF、PVV、PVD和HAF分别为(871.3±91.5)ml/min、(41.5±3.8)cm/s、(1.0±0.2)cm和(872.2±29.7)ml/min,与开腹组【分别为(904.7±87.3)ml/min、(39.7±3.4)cm/s、(1.1±0.2)cm和(881.6±30.5)ml/min】比,无显著性差异(P>0.05);术后6 m,两组肝功能指标比较,无显著性差异(P>0.05);腔镜组血浆ET、ATⅡ和PRA水平分别为(74.7±5.1)ng/L、(143.3±7.6)ng/L和(71.5±7.9)ng/L,与开腹组【分别为(76.5±6.3)ng/L、(146.7±9.6)ng/L和(73.4±7.6)ng/L,P>0.05】比,无显著性差异。结论采取腹腔镜下脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压并发EV患者可达到与开腹手术相同的疗效,对门脉血流动力学的影响与开腹手术也相差不大。

关键词: 肝硬化, 食管胃底静脉曲张, 腹腔镜脾切除, 贲门周围血管离断术, 门脉血流动力学

Abstract: Objective The aim of this study was to compare the laparoscopic and open splenectomy and pericardial devascularization in treatment of cirrhotics with esophageal varice (EV) and its impact on portal hemodynamics. Methods 45 cirrhotic patients with EV were enrolled in our hospital between March 2016 and March 2021, and 20 patients received open and another 25 patients received laparoscopic splenectomy and pericardial devascularization. Plasma endothelin (ET), angiotensin II (ATII) and plasma renin activity (PRA) were detected by radioimmunoassay. The portal vein flow (PVF), portal vein velocity (PVV), portal vein diameter (PVD) and hepatic arterial flow (HAF) were measured by Doppler ultrasonography. Results The operation time, intraoperative blood loss, blood transfusion volume, removal of drainage tube, postoperative exhaust and suture removal in patients receiving laparoscopic surgery were (213.5±20.7)min, (362.8±56.9)ml, (312.5±20.7)ml, (3.8±0.6)d, (2.7±0.4)d and (7.9±1.5)d, significantly different as compared to [(188.4±16.9)min,(415.2±50.7)ml, (349.4±23.6)ml, (5.1±0.9)d,(3.2±0.5)d and (11.3±2.1)d, respectively, P<0.05] in patients receiving open operation; at the end of one month after operation, the PVF, PVV, PVD and HAF in laparoscopic surgery-treated patients were (871.3±91.5)ml/min, (41.5±3.8)cm/s, (1.0±0.2)cm and (872.2±29.7) ml/min, not significantly different compared to [(904.7±87.3)ml/min, (39.7±3.4)cm/s, (1.1±0.2)cm and (881.6±30.5)ml/min, P>0.05] in open operation-treated patients; at the end of six months after surgery, there were no significant differences respect to liver function tests between the two groups (P>0.05); plasma ET, ATⅡ and PRA in laparoscopic surgery-treated patients were (74.7±5.1)ng/L, (143.3±7.6)ng/L and (71.5±7.9)ng/L, not significantly different compared to [(76.5±6.3)ng/L, (146.7±9.6)ng/L and (73.4±7.6)ng/L, respectively, P>0.05] in open operation-treated patients. Conclusion The laparoscopic splenectomy and pericardial devascularization might obtain the same efficacy of open operation in cirrhotics with EV, and the portal hemodynamics after operation is getting smooth.

Key words: Liver cirrhosis, Esophageal varice, Laparoscopic splenectomy, Pericardial devascularization, Portal hemodynamics

李嘉兴, 伍丽霞, 尹承龙, 欧阳俊光, 郭永学, 莫奇霏, 王金重. 腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压并发食管胃底静脉曲张患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(2): 258-261.

Li Jiaxing, Wu Lixia, Yin Chenglong, et al.. Laparoscopic splenectomy and pericardial devascularization in treatment of cirrhotics with esophageal varice and its impact on portal hemodynamics[J]. Journal of Practical Hepatology, 2023, 26(2): 258-261.

参考文献

[1] Lyu Y, Bai W, Li K, et al. Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: a prospective observational study. Am J Gastroenterol, 2021, 116(7): 1447-1464.
[2] Zhang H, Zhang S, Zhang J, et al. Improvement of human platelet aggregation post-splenectomy with paraesophagogastric devascularization in chronic hepatitis B patients with cirrhotic hypersplenism. Platelets, 2020, 31(8): 1019-1027.
[3] Kang SH, Lee M, Kim MY, et al. The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study. Hepatol Int, 2021, 15(2): 424-436.
[4] Yang L, Zhang Z, Zheng J, et al. Long‐term outcomes of oesophagogastric devascularization and splenectomy in patients with portal hypertension and liver cirrhosis. ANZ J Surg, 2020, 90(11): 2269-2273.
[5] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会. 肝硬化门静脉高压食管胃静脉曲张破裂出血的防治指南. 实用肝脏病杂志, 2016, 55(1): 57-72.
[6] 中华医学会消化病学分会, 肝病学分会, 内镜学分会. 肝硬化门静脉高压食管胃静脉曲张破裂出血的防治共识. 中华肝脏病杂志, 2008, 16(8): 564-570.
[7] 刘公伟, 吴雪, 唐聃, 等. 脾切除联合门奇静脉断流术治疗乙型肝炎肝硬化门脉高压症患者疗效研究. 实用肝脏病杂志, 2021, 24(5): 649-652.
[8] Boyer-Diaz Z, Aristu-Zabalza P, Andrés-Rozas M, et al. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease. J Hepatol, 2021, 74(5): 1188-1199.
[9] 代坤甫, 马帅, 郝晓沛, 等. 腹腔镜脾切除联合贲门周围血管离断术对肝硬化门静脉高压症患者应激和免疫功能的影响. 中华普通外科杂志, 2019, 34(7): 609-612.
[10] Kreisel W, Schaffner D, Lazaro A, et al. Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension. Int J Mol Sci, 2020, 21(17): 6223-6229.
[11] 韩东, 彭经纬, 谢辉晋. 脾切除联合贲门周围血管离断术治疗肝硬化门脉高压症患者预防门静脉血栓形成研究. 实用肝脏病杂志, 2020, 23(3): 409-412.
[12] 阿思根, 夏医君, 武慧军, 等. 脾切除术联合门奇静脉断流术治疗肝硬化门脉高压症患者疗效研究. 实用肝脏病杂志, 2020, 23(2): 248-251.
[13] Zheng D, Yu J, Li H, et al. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series. Medicine, 2021, 100(27): e26610.
[14] Deng ZC, Jiang WZ, Chen L, et al. Laparoscopic vs. open splenectomy and oesophagogastric devascularisation for liver cirrhosis and portal hypertension: A retrospective cohort study. Int J Surg, 2020, 80(8): 79-83.
[15] Fujinaga A, Ohta M, Endo Y, et al. Clinical significance of splenic vessels and anatomical features in laparoscopic splenectomy. J Laparoendosc Adv Surg Tech A, 2021, 31(6): 632-637.
[16] 谢飞, 王杰, 牟廷刚, 等. 不同时间窗抗凝对腹腔镜脾切除联合贲门周围血管离断术后患者门静脉血栓形成的预防作用. 中华肝胆外科杂志, 2019, 25(6): 435-438.
[17] Fernández J, Clària J, Amorós A, et al. Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis. Gastroenterology, 2019, 157(1): 149-162.
[18] Gelman S, Sakalauskas A, Zykus R, et al. Endogenous motion of liver correlates to the severity of portal hypertension. World J Gastroenterol, 2020, 26(38): 5836-5848.
[19] 蒋国庆, 柏斗胜, 金圣杰, 等. 改良保留迷走神经与传统腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压症的前瞻性随机对照研究. 中华消化外科杂志, 2020, 19(12): 1280-1285.
[20] 汪昱, 董科. 改良腹腔镜脾脏切除+贲门周围血管离断术在肝硬化合并门静脉高压症中的应用研究. 中华普外科手术学杂志: 电子版, 2021, 15(1): 65-68.
[21] Yao H, Wang Y. Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension. Open Life Sci, 2020, 15(1): 981-987.
[22] Simbrunner B, Semmler G, Stadlmann A, et al. Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis. Hepatol Int, 2020, 14(6): 1093-1103.
[23] Artru F, Miquet X, Azahaf M, et al. Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance. Aliment Pharmacol Ther, 2020, 52(9): 1516-1526.

腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压并发食管胃底静脉曲张患者疗效研究^*

Laparoscopic splenectomy and pericardial devascularization in treatment of cirrhotics with esophageal varice and its impact on portal hemodynamics

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	程洋, 张峰, 王曦旋, 尹晓春, 肖江强, 张明, 王雷, 邹晓平, 诸葛宇征. 普萘洛尔与卡维地洛预防肝硬化患者并发食管胃静脉曲张破裂出血临床疗效比较^*[J]. 实用肝脏病杂志, 2023, 26(2): 254-257.
[2]	张斌, 赵宇亮, 闫国贝. hUCB-MNCs联合hUC-MSCs静脉输注治疗失代偿期乙型肝炎肝硬化患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(2): 262-265.
[3]	周秋娟, 朱逸明, 马宇航, 陈婷闪. TIPS与PSE术治疗乙型肝炎肝硬化并发脾功能亢进症患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(2): 266-269.
[4]	黄姝伦, 贺胜铎, 徐小元, 王化虹. 部分肠内营养联合奥曲肽治疗肝硬化乳糜性腹水1例报告[J]. 实用肝脏病杂志, 2023, 26(2): 290-292.
[5]	吴鹏, 高柳村, 汤善宏. 应用人工智能技术诊治肝脏疾病研究进展[J]. 实用肝脏病杂志, 2023, 26(2): 293-296.
[6]	中华医学会肝病学分会中华医学会消化病学分会中华医学会消化内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 实用肝脏病杂志, 2023, 26(2): 0-S4.
[7]	徐海波, 苏惠婷, 熊异平, 徐远久, 邓强. 乙型肝炎肝硬化患者外周血dNLR、MLR和SII变化及其临床意义分析^*[J]. 实用肝脏病杂志, 2023, 26(1): 71-74.
[8]	李苏苏, 董媛, 贾浩延, 秦颖. 门冬氨酸鸟氨酸联合结肠透析治疗肝性脑病患者疗效及其对血浆β-EP和LPS的影响^*[J]. 实用肝脏病杂志, 2023, 26(1): 75-78.
[9]	陈晔, 陈晓岚, 曹丽玲, 刘昌华. 接受TIPS治疗的肝硬化患者术后心脏结构与功能指标的变化评价^*[J]. 实用肝脏病杂志, 2023, 26(1): 79-82.
[10]	刘南南, 李卫, 赵守松. 简化版动物命名试验对肝硬化并发轻微性肝性脑病的诊断价值及相关因素分析^*[J]. 实用肝脏病杂志, 2023, 26(1): 83-86.
[11]	戴欢, 李凯, 朱永湘, 王超. 内镜下套扎和注射硬化剂治疗乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(1): 87-90.
[12]	许青, 杨健, 宗金娟. 特发性非肝硬化门静脉高压症患者肝脏影像学和病理学特征分析^*[J]. 实用肝脏病杂志, 2023, 26(1): 91-94.
[13]	吴笛, 罗业浩, 黄安. 肝巨噬细胞极化对肝硬化发生的影响及临床应用研究进展^*[J]. 实用肝脏病杂志, 2023, 26(1): 149-152.
[14]	韩涛, 刘艳迪, 胡家轩. 肝病合并肾损伤临床诊治新进展[J]. 实用肝脏病杂志, 2022, 25(6): 761-763.
[15]	蒋莹莹, 丁惠国. 肝硬化并发急性肾损伤临床管理现状与挑战[J]. 实用肝脏病杂志, 2022, 25(6): 764-767.